EXAMINE THIS REPORT ON PENTOBARBITAL DRUG

Contraindicated. Coadministration of doravirine with a powerful CYP3A inducer may perhaps lower doravirine plasma concentrations and/or effects. Potential for loss of virologic response and attainable resistance to doravirine.pentobarbital will lessen the level or effect of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use